1 / 18

DIURETICS: (know those used to Tx hypertension and HF) Thiazide diuretics: hydrochlorothiazide

Normal renal function:. urine output (pressure diuresis). MAP  renal perfusion. salt output (pressure natriuresis). Davidoff ‘09. DIURETICS: (know those used to Tx hypertension and HF) Thiazide diuretics: hydrochlorothiazide Loop diuretics: furosemide, ethacrynic acid

louis-ford
Download Presentation

DIURETICS: (know those used to Tx hypertension and HF) Thiazide diuretics: hydrochlorothiazide

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Normal renal function: urine output (pressure diuresis) MAP  renal perfusion salt output (pressure natriuresis) Davidoff ‘09 • DIURETICS: • (know those used to Tx hypertension and HF) • Thiazide diuretics: hydrochlorothiazide • Loop diuretics: furosemide, ethacrynic acid • Potassium-sparing diuretics: • spironolactone, eplerenone, amiloride • Osmotic diuretics: mannitol • Carbonic anhydrase inhibitors: acetazolamide

  2. Rationale for using diuretics For heart failure: Blood volume  preload (cardiac work) congestion (edema) For hypertension:  Blood volume and peripheral resistance   preload (ventricular filling)   CO   BP • Diuretics promote natriuresis (Na+ excretion) • Water tends to follow Na+ (diuresis) • Relative potencies of diuretics: • Loops >> Thiazides >>>>>> K+ sparing

  3. Na+ Ca2+ reabsorption Thiaz filtration K+ sparing Na+ secretion Na+ +ALD Loops K+ H+ +ADH Katzung Fig 15-1

  4. Thiazides: hydrochlorothiazide • Most commonly used class of diuretics • Differ in their pharmacokinetics • Indicated for mild hypertension • short-term effects  blood volume • long-term effects TPR (lose their diuretic effects) • For moderate or severe hypertension, • used in combination with other antihypertensive drugs • Flat dose-response curve • (i.e., increasing dose does not make them more effective)

  5. loss of diuresis is fast Brenner Fig 10-2

  6. With whom should care be taken? • Thiazides: (con’t) • Na+ reabsorption by inhibiting Na/Cl co-transport in the distal • convoluted tubule • Modest effect because only 5-10% of Na+ is reabsorbed there • Must be filtered or secreted to work, therefore ineffective • in patients with renal insufficiency/failure • Require renal prostaglandins to work, therefore NSAIDs can • interfere with diuresis • Side effects: • Hypokalemic metabolic alkalosis • Blood glucose, lipids, and uric acid Bonus: Blood Ca2+ (via Ca2+ reabsorption) useful for osteoporosis  Urine Ca2+ useful for kidney stones

  7. How do thiazides (and loops) promote K+ loss? Na+ K+ H Loss Na+ tubular Na+ collecting duct Na+ K+ H loss Na+/K+ exchange urine urine

  8. Loop diuretics: furosemide, ethacrynic acid • “High ceiling diuretics” - work in a dose-dependent manner • Ethacrynic acid is an alternative if patient has sulfonamide allergy • Extremely effective, rapid onset • Indicated for severe edema (e.g., pulmonary edema, CHF) • not typically used for hypertension • Inhibit Na/K/2Cl transport in ascending loop of Henle • normally responsible for ~35% Na+ reabsorption • Are filtered and secreted • Directly increase renal blood flow, therefore effective with renal insufficiency

  9. 'high ceiling diuretics' Diuresis 'flat D-R curve' Dose of diuretic Brenner Fig 13-3

  10. Like Thiazides: Loops require renal prostaglandins to work, therefore NSAIDs can interfere with diuresis • Side effects include: • Hypokalemic metabolic alkalosis and hyperuricemia • Hypovolemia • Ototoxicity Loops greater incidence of adverse side effects than thiazides

  11. Na+ Ca2+ reabsorption Thiaz filtration K+ sparing Na+ secretion Na+ +ALD Loops K+ H+ +ADH Katzung Fig 15-1

  12. Potassium sparing ‘diuretics’ Spironolactone, Eplerenone, Amiloride • Weak diuretics • used in combination with other diuretics • Antagonize aldosterone effects • Aldosterone is a steroid • binds to mineralocorticoid receptors in tubular epithelial cells • stimulates the synthesis of Na/K/H pumps • promotes Na+ reabsorption, K+/H+ secretion • Prevents hypokalemia from thiazide and loop diuretics • Must be cautious of hyperkalemia

  13. Spironolactone • Competitively binds to aldosterone receptors - nonselective • (mineralocorticoid, androgenic and progesterone receptors) • Inhibits aldosterone-induced synthesis of pumps • Slow onset (WHY?), long duration (active metabolites) • Weak naturiuretic effects, but lowers BP in some patients with mild/moderate hypertension • Also indicated for hyperaldosteronemia • Shown to improve morbidity and mortality in patients with end-staged heart failure (Pitt et al., NEJM, 1999) • Side effects include: • Men: gynecomastia and erectile dysfunction because of anti-androgenic actions • Women: menstrual irregularities, hirsutism

  14. Eplerenone • More specific for aldosterone receptors than spironolactone therefore avoids side effects • (but really expensive) • Currently approved hypertension and post-MI LV dysfunction • CYP450 3A4 inhibitors (e.g., erythromycin, verapamil, and grapefruit juice) can elevate blood levels of eplerenone • Aldosterone is also associated with endothelial dysfunction and fibrotic effects in hypertension, HF and atherosclerosis • (mechanism underlying ACE-I cardioprotection???) • Cardioprotective effects appear similar to spironolactone http://www.jaapa.com/issues/j20040201/articles/0204wcardiomeds.html

  15. Amiloride • Directly inhibits pumps in distal tubules and collecting ducts • therefore independent of aldosterone • (blocks Na+ selective channels in apical membrane) • Onset of action much faster than spironolactone • does not involve gene expression • Relatively few side effects (caution about hyperkalemia)

  16. JNC VII Compelling Indications for Drug Classes Clinical-Trial Basis Compelling Indication Initial Therapy Options MERIT-HF, COPERNICUS, CIBIS, SOLVD, AIRE, TRACE, Val-HeFT, RALES Heart Failure Diuretic, BB, ACEI,ARB, Aldo Ant ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS BB, ACEI, Aldo Ant Post-MI ALLHAT, HOPE, ANBP2,LIFE, CONVINCE High CAD Risk Diuretic, BB, ACEI, CCB NKF-ADA Guideline,UKPDS, ALLHAT Diuretic, BB, ACEI,ARB, CCB Diabetes Mellitus NKF Guideline, Captopril Trial, RENAAL, IDNT, REIN, AASK Chronic Kidney Disease ACEI, ARB Recurrent Stroke Prevention Diuretic, ACEI PROGRESS ACEI=Angiotensin converting enzyme inhibitor, Aldo Ant=Aldosterone antagonist, ARB=Angiotensin receptor blocker, BB=b-blocker, CAD=Coronary artery disease, CCB=Calcium channel blocker, MI=Myocardial Infarction Chobanian AV et al. JAMA. 2003;289:2560-2572

More Related